Cargando…
Hes1 attenuates type I IFN responses via VEGF-C and WDFY1
Induction of type I interferons (IFNs) is critical for eliciting competent immune responses, especially antiviral immunity. However, uncontrolled IFN production contributes to pathogenesis of autoimmune and inflammatory diseases. We found that transcription factor Hes1 suppressed production of type...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547865/ https://www.ncbi.nlm.nih.gov/pubmed/31015298 http://dx.doi.org/10.1084/jem.20180861 |
_version_ | 1783423769826557952 |
---|---|
author | Ning, Fei Li, Xiaoyu Yu, Li Zhang, Bin Zhao, Yuna Liu, Yu Zhao, Baohong Shang, Yingli Hu, Xiaoyu |
author_facet | Ning, Fei Li, Xiaoyu Yu, Li Zhang, Bin Zhao, Yuna Liu, Yu Zhao, Baohong Shang, Yingli Hu, Xiaoyu |
author_sort | Ning, Fei |
collection | PubMed |
description | Induction of type I interferons (IFNs) is critical for eliciting competent immune responses, especially antiviral immunity. However, uncontrolled IFN production contributes to pathogenesis of autoimmune and inflammatory diseases. We found that transcription factor Hes1 suppressed production of type I IFNs and expression of IFN-stimulated genes. Functionally, Hes1-deficient mice displayed a heightened IFN signature in vivo, mounted enhanced resistance against encephalomyocarditis virus infection, and showed signs of exacerbated experimental lupus nephritis. Mechanistically, Hes1 did not suppress IFNs via direct transcriptional repression of IFN-encoding genes. Instead, Hes1 attenuated activation of TLR upstream signaling by inhibition of an adaptor molecule, WDFY1. Genome-wide assessment of Hes1 occupancy revealed that suppression of WDFY1 was secondary to direct binding and thus enhancement of expression of VEGF-C by Hes1, making Vegfc a rare example of an Hes1 positively regulated gene. In summary, these results identified Hes1 as a homeostatic negative regulator of type I IFNs for the maintenance of immune balance in the context of antiviral immunity and autoimmune diseases. |
format | Online Article Text |
id | pubmed-6547865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-65478652019-12-04 Hes1 attenuates type I IFN responses via VEGF-C and WDFY1 Ning, Fei Li, Xiaoyu Yu, Li Zhang, Bin Zhao, Yuna Liu, Yu Zhao, Baohong Shang, Yingli Hu, Xiaoyu J Exp Med Research Articles Induction of type I interferons (IFNs) is critical for eliciting competent immune responses, especially antiviral immunity. However, uncontrolled IFN production contributes to pathogenesis of autoimmune and inflammatory diseases. We found that transcription factor Hes1 suppressed production of type I IFNs and expression of IFN-stimulated genes. Functionally, Hes1-deficient mice displayed a heightened IFN signature in vivo, mounted enhanced resistance against encephalomyocarditis virus infection, and showed signs of exacerbated experimental lupus nephritis. Mechanistically, Hes1 did not suppress IFNs via direct transcriptional repression of IFN-encoding genes. Instead, Hes1 attenuated activation of TLR upstream signaling by inhibition of an adaptor molecule, WDFY1. Genome-wide assessment of Hes1 occupancy revealed that suppression of WDFY1 was secondary to direct binding and thus enhancement of expression of VEGF-C by Hes1, making Vegfc a rare example of an Hes1 positively regulated gene. In summary, these results identified Hes1 as a homeostatic negative regulator of type I IFNs for the maintenance of immune balance in the context of antiviral immunity and autoimmune diseases. Rockefeller University Press 2019-06-03 2019-04-23 /pmc/articles/PMC6547865/ /pubmed/31015298 http://dx.doi.org/10.1084/jem.20180861 Text en © 2019 Ning et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Research Articles Ning, Fei Li, Xiaoyu Yu, Li Zhang, Bin Zhao, Yuna Liu, Yu Zhao, Baohong Shang, Yingli Hu, Xiaoyu Hes1 attenuates type I IFN responses via VEGF-C and WDFY1 |
title | Hes1 attenuates type I IFN responses via VEGF-C and WDFY1 |
title_full | Hes1 attenuates type I IFN responses via VEGF-C and WDFY1 |
title_fullStr | Hes1 attenuates type I IFN responses via VEGF-C and WDFY1 |
title_full_unstemmed | Hes1 attenuates type I IFN responses via VEGF-C and WDFY1 |
title_short | Hes1 attenuates type I IFN responses via VEGF-C and WDFY1 |
title_sort | hes1 attenuates type i ifn responses via vegf-c and wdfy1 |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547865/ https://www.ncbi.nlm.nih.gov/pubmed/31015298 http://dx.doi.org/10.1084/jem.20180861 |
work_keys_str_mv | AT ningfei hes1attenuatestypeiifnresponsesviavegfcandwdfy1 AT lixiaoyu hes1attenuatestypeiifnresponsesviavegfcandwdfy1 AT yuli hes1attenuatestypeiifnresponsesviavegfcandwdfy1 AT zhangbin hes1attenuatestypeiifnresponsesviavegfcandwdfy1 AT zhaoyuna hes1attenuatestypeiifnresponsesviavegfcandwdfy1 AT liuyu hes1attenuatestypeiifnresponsesviavegfcandwdfy1 AT zhaobaohong hes1attenuatestypeiifnresponsesviavegfcandwdfy1 AT shangyingli hes1attenuatestypeiifnresponsesviavegfcandwdfy1 AT huxiaoyu hes1attenuatestypeiifnresponsesviavegfcandwdfy1 |